Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

MEA Blood Coagulants Companies Companies

Several companies in the Middle East and Africa region are involved in the development and distribution of blood coagulants. These companies play a crucial role in providing healthcare solutions related to hemostasis and coagulation disorders.

Middle East & Africa Blood Coagulants Key Companies

Latest MEA Blood Coagulants Companies Update

Nov 2023: As both pharmaceutical companies struggle to meet demand, Novo Nordisk and Eli Lilly announced phenomenal sales from the current crop of diabetic and weight-loss medications they have pioneered. Novo, a Danish company, recorded $8.4 billion in revenue during the last three months, up 29% over the same period last year. More than half of sales were attributed to the company's popular medications, Wegovy and Ozempic. Lilly, an Indianapolis-based company, reported $9.5 billion in revenue for the most recent quarter—a 37 percent rise—driven primarily by Mounjaro's rapidly expanding sales. In the weight-loss medicine craze that has enthralled consumers and captured Wall Street's attention, the two businesses have emerged as the leading forces. With the aid of a new production plant in North Carolina that opened this year, Lilly has increased the supply of Mounjaro, and the FDA's drug shortage database lists all of the medication's strengths as available. Despite having differing chemical compositions, Mounjaro and Ozempic both slow the emptying of the stomach and assist control blood sugar.

List of MEA Blood Coagulants Key companies in the market

Pfizer Inc. (U.S.)

Bayer AG (Germany)

Novo Nordisk AS (Dernmark)

Shire (Republic of Ireland)

SOBI (Sweden)

Octapharma (Switzerland)

CSL Limited (Australia)

Blood Coagulants Market Highlights:

Blood Coagulants Market Size

Blood Coagulants Market Trends

Blood Coagulants Market Analysis

Blood Coagulants Market Share

Blood Coagulants Market Highlights:

Blood Coagulants Market Trends

Blood Coagulants Market Analysis

Blood Coagulants Market Share

Blood Coagulants Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.